Rev-erbα gives a time cue to metabolism  by Duez, Hélène & Staels, Bart
FEBS Letters 582 (2008) 19–25Minireview
Rev-erba gives a time cue to metabolism
He´le`ne Duez, Bart Staels*
Institut Pasteur de Lille, Lille F-59019, France
INSERM U545, Institut Pasteur de Lille, 1, Rue Calmette, B.P. 245, Lille F-59019, France
Universite´ de Lille 2, Faculte´ des Sciences Pharmaceutiques et Biologiques et Faculte´ de Medecine, Lille F-59019, France
Received 11 June 2007; revised 13 August 2007; accepted 14 August 2007
Available online 24 August 2007
Edited by Peter Tontonoz and Laszlo NagyAbstract Normal physiological processes are under control of
circadian rhythms. Moreover, certain pathological events, such
as cardiovascular accidents (myocardial infarction, stroke) occur
more frequently at speciﬁc times of the day. Recent observations
demonstrate a causal relationship between alterations in circa-
dian rhythmicity and metabolic disorders. Disruption of clock
genes results in dyslipidemia, insulin resistance and obesity, all
predisposing to atherosclerosis. The nuclear receptor Rev-erba
is part of the clock circuitry and plays an important role in keep-
ing proper timing of the clock. Rev-erba also regulates lipid
metabolism, adipogenesis and vascular inﬂammation. Interest-
ingly, Rev-erba also cross-talks with several other nuclear recep-
tors involved in energy homeostasis. Therefore Rev-erba may
serve to couple metabolic and circadian signals.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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The organism exerts a tight control on key metabolic events
in order to assure energy homeostasis and fuel availability.
Nuclear receptors are a family of transcription factors involved
in the regulation of many aspects of energy homeostasis,
including lipid utilisation or storage, cholesterol synthesis
and elimination, insulin signalling and glucose metabolism.
Abnormalities in these pathways, for instance due to genetic
disorders, high caloric intake or low energy expenditure, lead
to metabolic disorders such as dyslipidemia, obesity, insulin
resistance and type 2 diabetes. These abnormalities often
co-exist and are referred to as the metabolic syndrome [1]
which also comprises an inﬂammatory component charac-
terized by over-secretion of adipokines by the adipose tissue
[2].
Many physiological processes are under the control of circa-
dian (‘‘around the day’’ = circa diem) rhythms that provide the
organism a selective advantage by allowing its metabolism to
adapt to predictable daily changes such as day–night, activ-
ity–rest cycles, and time of food availability. The master clock*Corresponding author. Fax: +33 3 20 87 73 60.
E-mail address: Bart.Staels@pasteur-lille.fr (B. Staels).
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doi:10.1016/j.febslet.2007.08.032is located in the suprachiasmatic nucleus (SCN) of the hypo-
thalamus and consists of a complex circuitry of transcrip-
tional/post-translational regulatory loops able to initiate and
self-sustain biological rhythms. It synchronises peripheral
autonomous pacemakers in order to coordinate and adjust
organ physiology to environmental timing cues. Lipid and
carbohydrate metabolism, hormone (insulin, leptin, and corti-
sol) secretion, blood pressure, coagulation factors and feeding
behavior are a few examples of many aspects of mammalian
physiology that are subjected to circadian oscillations. Thus,
disturbance of circadian rhythms may have clinical implica-
tions in the development of dyslipidemia, obesity and cardio-
vascular events.
Indeed, circadian rhythms in both insulin secretion and sen-
sitivity are altered in type 2 diabetic patients [3]. A recent clin-
ical report revealed that sleep restriction is an independent risk
factor for obesity and hypertension [4]. In the same line of evi-
dence, components of the metabolic syndrome occur at higher
frequency in shift work and night eating conditions [5,6].
Finally, circadian rhythms observed in the expression of adipo-
kines, leptin, adiponectin are blunted in obese and diabetic ani-
mals [7] and obese humans [8,9]. These ﬁndings corroborate
the existence of a link between circadian oscillations and
metabolism.
A growing body of evidence shows that clock genes directly
inﬂuence energy homeostasis and that deﬁciency in clock genes
leads to metabolic disorders resembling the metabolic syn-
drome. Turek et al. have shown that mice with a mutated
non-functional clock gene are hyperphagic, become obese
and develop hyperlipidemia and hyperglycemia [10]. Another
report indicates that a mutation in clock and Bmal1 leads to
altered circadian oscillations in plasma glucose and triglyceride
levels, and mice harbouring these mutations develop glucose
intolerance [11]. These observations emphasize the direct link
between circadian rhythmicity and metabolism and point to
a causal relationship between clock disorders and metabolic
unbalance. Importantly, they suggest that clock genes them-
selves, directly or indirectly, are involved in the control of en-
ergy homeostasis. The nuclear receptor Rev-erba has been
identiﬁed as a clock and clock-regulated gene [12]. It is part
of the core clock machinery and serves to maintain a 24-h
cycle. Simultaneously, Rev-erba plays a crucial regulatory role
in metabolism. For instance, it regulates triglyceride (TG) and
TG-rich lipoprotein metabolism [13] and modulates adipogen-
esis [14]. It may also play a determinant role in the regulation
of systemic and vascular inﬂammatory processes [15]. Here, we
will review the known physiological functions of Rev-erba andblished by Elsevier B.V. All rights reserved.
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molecular link between circadian metabolic changes and the
general clock system.2. Clock genes and nuclear receptors: interacting partners in
metabolic control
Circadian rhythms are generated by a master clock system
located in the SCN. Recently, however, it was shown that
peripheral self-sustained oscillators operate in virtually all cell
types and autonomously generate oscillations in peripheral
tissues. Feeding/fasting is the most dominant time cue for
peripheral tissues [16]. The synchronization of those oscillators
involves hormonal and neuronal signals from the SCN master
clock which itself is reset by light via the retino-hypothalamic
nerve tract. To elucidate the respective role of the central vs
peripheral clock in the regulation of the hepatic circadian pro-
gram, Schibler and colleagues have engineered a conditionally
active liver clock mouse model. This was achieved by over-
expressing Rev-erba throughout the day, resulting in a sup-
pression of Bmal1 oscillations and turning oﬀ the clock
machinery [17]. In this mouse model, oscillation of most hepa-
tic transcripts was dampened strengthening the idea that a
functional liver clock is necessary to ensure proper circadian
regulation of hepatic gene expression.
Under normal conditions, around 10% of hepatic transcripts
oscillate diurnally [18] and microarray analyses of liver mRNA
demonstrated that a large number of these genes are involved
in metabolic processes such as food processing, fuel utilization/
storage, etc. For instance, genes encoding enzymes and trans-
porters involved in nutrient metabolism, cellular cholesterol
homeostasis, xenobiotic detoxiﬁcation or energy balance such
as phosphoenolpyruvate carboxykinase (PEPCK), cholesterol
7a-hydroxylase (CYP7A1), the glucose transporter Glut2,
etc., display circadian expression. As sensors of small fat-solu-
ble molecules such as hormones or fatty acids derived from
intermediate metabolism or food, nuclear receptors are keyFig. 1. Rev-erba is a clock and a clock-controlled gene. The cartoon depicts
the positive (Clock/Bmal1) and the negative (Per/Cry) limb of the pacema
circadian rhythms.players in endocrine regulation. A recent report indicates that
28 out of 48 nuclear receptors display cyclic expression in met-
abolically active tissues (liver, adipose tissue, and skeletal mus-
cle), strongly suggesting that circadian oscillations in
expression of these regulatory proteins may co-ordinately
entrain daily variations in their target genes and couple the
peripheral clock to metabolic output [19]. In this context,
Rev-erba may play a central role in participating in the tempo-
ral coordination of metabolism.3. Rev-erba is a clock and a clock-regulated gene
At the molecular level, circadian rhythms are generated
through the reciprocal regulation of two interlocked transcrip-
tional and post-translational auto-regulatory feedback loops.
In mammals, Clock (Circadian locomotor output cycles
kaput), Bmal1 (Brain and muscle ARNt like protein 1), and
possibly the clock paralog NPAS2, form the positive limb
and activate transcription of per (Period) and cry (Crypto-
chrome) genes, with per1, per2, cry1 and cry2 forming the neg-
ative limb [20] (Fig. 1). Once the proteins Per and Cry reach a
critical concentration, they enter the nucleus and inhibit Clock/
Bmal1 transactivation, thereby repressing their own transcrip-
tion. Rev-erba transcription is activated by Clock/Bmal1 and
trans-repressed by Per/Cry, resulting in circadian oscillations
of Rev-erba. In turn, Rev-erba periodically represses Bmal1
and to a lesser extent clock transcription, thereby interconnect-
ing the positive and negative loops. Ueli Schibler and collabo-
rators ﬁrst evidenced a critical role of Rev-erba in the clock
machinery in vivo showing that Rev-erba-deﬁcient mice dis-
play markedly altered circadian rhythms characterized by in-
creased Bmal1 and Clock expression and a shorter period
length than wild-type mice [12]. Moreover, light pulse delivery
late in the night provoked drastic phase advances in Rev-erba-
deﬁcient mice compared to wild-type. However, Rev-erba-deﬁ-
cient mice are not arrhythmic, suggesting that Rev-erba is re-
quired for the maintenance and robustness rather than thea simpliﬁed model of the circadian machinery in which Rev-erba links
ker. Rev-erba serves to ensure proper phase length and strengthens
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in which ROR and Rev-erba compete for the regulation
(induction vs repression) of the positive limb [21,22]. Of note,
Rev-erbb also displays a strong diurnal expression pattern
and represses Bmal1 transcription [23]. Since the three ROR
isoforms do not all cycle in the same tissues, we hypothesize
that the ratio between each isoform of ROR and Rev-erb
might aﬀect the regulation of the positive limb in a tissue-spe-
ciﬁc manner and may oﬀer the opportunity to ﬁnely tune the
circadian network to nutrient and energy metabolism.
Post-translational mechanisms (i.e. protein phosphorylation)
are likely to play a regulatory role aswell. They inﬂuence per and
cry protein stability andmay therefore be critical to their activity
[24]. Lazar and colleagues have recently shown that the glycogen
synthase kinase (GSK)3 stabilizes the Rev-erba protein and that
lithium, a potent inhibitor of GSK3, induces Rev-erba degrada-
tion. In the presence of a mutant form of Rev-erba, that is resis-
tant to degradation by lithium, a serum shock could not initiate
circadian oscillation in cells [25]. Rev-erba protein stability is
therefore crucial for circadian rhythm initiation, maintenance
and synchronisation after serum shock.4. Rev-erba: an orphan nuclear receptor with atypical features
Rev-erba belongs to the superfamily of nuclear receptors. It
is still considered as an ‘‘orphan receptor’’ since no ligand has
been identiﬁed sofar. Furthermore, it lacks the AF2 ligand-Fig. 2. Control of Rev-erba transcription. Rev-erba negatively regulates expr
dimeric (RevDR-2) response elements. Rev-erba also competes for binding wdependent transactivation domain and its ligand binding pock-
et is ﬁlled up by amino-acid side chains leaving little room to
accommodate a putative ligand [26]. Rev-erbb, the other
isotype of the Rev-erb family sharing high homology with
Rev-erba, has still not been adopted either.
Rev-erba is encoded on the opposite strand of the thyroid
receptor (TR)a gene [27]. The Rev-erba gene overlaps with
269 nucleotides the splice variant TRa2 and it has been sug-
gested that Rev-erba may inﬂuence the TRa1/TRa2 ratio,
thereby possibly altering TRa signalling. However this hypoth-
esis has sofar not been corroborated in vivo and Rev-erba-deﬁ-
cient mice have been shown to have TRa1 and TRa2 levels
within the normal range ([28], and C. Fontaine and B. Staels,
unpublished data). Triqueneaux et al. recently demonstrated
that alternative promoter and splicing site usage gives rise to
two Rev-erba isoforms Rev-erba1 and Rev-erba2 [29].
Its orphan status and the peculiar arrangement of its geno-
mic locus are not the only atypical characteristics of this nucle-
ar receptor. Rev-erba displays a hydrophobic region to which
co-repressors such as NCoR are recruited [26]. As a conse-
quence Rev-erba behaves as a constitutive repressor of tran-
scription. Rev-erba binds either as a monomer to a speciﬁc
response element (RevRE) consisting of a 6 bp core motif
(A/G)GGTCA ﬂanked by an A/T-rich 5 0 sequence, or as a
homodimer to a RevDR2 element composed of a direct repeat
of the core motif spaced by two nucleotides [30,31] (Fig. 2).
Rev-erba also competes on these sites with the closely related
RAR-related orphan receptors RORs [32]. Indeed, RORa
and Rev-erba are co-expressed in many tissues and share theession of its target genes by binding to speciﬁc monomeric (RevRE) or
ith transcriptional activators such as ROR or PPARs.
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tion (activation vs repression, respectively). A good example of
that competition is the regulation of Rev-erba itself: the Rev-
erba promoter contains a RevDR-2 site to which it binds and
represses its own transcription [33]. RORa binds to the same
sequence and activates Rev-erba transcription [34].
The peroxisome proliferator-activated receptors (PPAR)a
and c also bind to the RevDR-2 sequence in the Rev-erba gene
promoter and activate its transcription [14,35]. Thus ligands of
PPARa (such as the ﬁbrate class of hypolipemiants) and
PPARc (such as the insulin sensitizing thiazolidinediones)
have been shown to increase Rev-erba expression and, interest-
ingly, Rev-erbamay mediate some of their physiological eﬀects
(see below).
Rev-erba is expressed in many tissues such as the liver, white
and brown adipose tissue, muscle, brain, and cell types such as
endothelial cells (ECs), vascular smooth muscle cells (VSMCs)
and macrophages [15,27,32,36]. Its expression increases during
the diﬀerentiation of pre-adipocytes into mature adipocytes
[14,37]. In vitro data had suggested that its expression de-
creases during myogenesis, but Rev-erba has been reported
to be highly expressed in muscle from adult mice [38]. A major
characteristic of Rev-erba expression is its very robust circa-
dian regulation in vitro in serum-synchronised ﬁbroblasts
[39], ex vivo in primary cultures of rat hepatocytes [40], as well
as in vivo in brain, liver, muscle, pancreas and white and
brown adipose tissue [18,19,40–42].
Because Rev-erba has no known ligand, circadian variations
in its expression, regulation by other nuclear receptors, compe-
tition for binding to shared response elements and post-tran-
scriptional modiﬁcations are likely to play crucial roles in the
modulation of its activity. In rodents, Rev-erba expression is
maximal during the light phase (around 4:00pm) and decreases
to reach a nadir during the dark phase. Thus not only is Rev-
erba a clock gene but also a clock-regulated gene which may
have potential metabolic implications. Indeed, Rev-erba likelyFig. 3. Rev-erba couples circadian rhythms and metabolic functions. Rev-e
receptor signalling pathways to bring about ﬂexibility in the metabolic adjuonly modulates transcription of its target genes when its expres-
sion is suﬃcient, while its activity is strongly reduced at night.
Feeding time is one of the major time cues in the synchroni-
zation of the peripheral clock [16], and time restriction to the
light instead of the dark phase in food availability inverses
the phase of circadian expression in mouse liver without aﬀect-
ing SCN circadian gene expression. Of interest is the fact that
glucocorticoids interfere in that process since mice harbouring
a hepato-speciﬁc deletion of the glucocorticoid receptor (GR)
invert their circadian liver gene expression more rapidly after
day-time shift of food availability [43]. Interestingly, Rev-erba
expression is down-regulated by glucocorticoids [40], and Rev-
erba may therefore play a role in phase adjustment to food
availability.5. Rev-erba and the metabolic syndrome
Dysregulations in metabolic pathways involved in lipid and
carbohydrate metabolism, and insulin signalling lead to meta-
bolic disorders such as obesity, dyslipidemia, insulin resistance
and eventually type 2 diabetes and hypertension. As other
members of the nuclear receptor family, Rev-erba has emerged
as a key regulator of diverse physiological processes such as
maintenance of energy homeostasis, adipogenesis and inﬂam-
mation.
5.1. Lipid and lipoprotein metabolism
The expression of apolipoprotein (apo) A–I, a major constit-
uent of high density lipoproteins (HDL), is repressed by Rev-
erba in rats [44]. Rev-erba is induced by PPARa and may
mediate the ﬁbrate-induced reduction of apoA-I gene expres-
sion and plasma HDL-cholesterol levels in rats (Fig. 3). This
regulation is lost in humans due to evolutionary sequence dif-
ferences in the RevRE present in the apoA-I gene promoter. In
contrast, Rev-erba represses both mouse and human apoC-IIIrba integrates signals from the circadian pacemaker and other nuclear
stments to environmental cues.
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apoC-III gene promoter adjacent to the TATA box [13].
Expression of apoC-III has been positively correlated with
the risk of cardiovascular disease, and Rev-erba may thus
act on factors determining atherosclerosis risk. In vivo, Rev-
erba-deﬁcient mice display increased hepatic apoC-III expres-
sion, plasma triglycerides (TG) and TG-rich very low density
lipoprotein (VLDL) particles [13,45]. Both apoA-I and
apoC-III are also regulated by RORa illustrating the cross-
talk of these nuclear receptors on common target genes. While
Rev-erba represses both apolipoproteins, RORa activates
their transcription after binding to the same response element
[46,47]. Moreover, staggerer mice which lack a functional
RORa gene display lowered apoA-I and apoC-III levels
[47,48]. More recently, it has been suggested that Rev-erba
might repress the expression of elovl3, a fatty acid elongase in-
volved in very long chain fatty acid (VLCFA) metabolism
although the in vivo relevance of this regulation is lacking
[49]. Finally, Rev-erba inhibits the expression of the enoylCoA
hydratase/3-hydroxyacylCoA dehydrogenase involved in the
peroxisomal b-oxidation pathway [50], and of the microsomal
cytochrome P450 fatty acid x-hydroxylase [51] by competing
with another nuclear receptor, namely PPARa. PPARa has
been shown to bind to the Bmal1 promoter and regulate its
expression [52] while the clock/Bmal1 heterodimer reciprocally
regulates PPARa [53]. This constitutes another interconnec-
tion in which a Rev-erba/PPARa regulatory loop may control
lipid metabolism in a circadian-dependent manner.
Rev-erba is also expressed in skeletal muscle where it ap-
pears to inﬂuence the myosin ﬁber type. Indeed, in the soleus
(‘‘red’’) muscle, Rev-erba-deﬁcient mice exhibit an increase
in the myosin heavy chain isoform speciﬁc of type I (b/slow-
twitch) muscles, which have a high content in mitochondria,
are involved in aerobic lipid metabolism and exhibit prolonged
exercise-induced energy mobilization [38]. Rev-erbb has also
been implicated in the regulation of muscle lipid metabolism
since ectopic expression of a dominant negative form increases
expression of genes involved in fatty acid uptake [54]. Rev-
erbb may also aﬀect the expression of IjB and cytokines such
as IL-6, although a concomitant increase in RORa expression
in the presence of the exogenous dominant negative Rev-erbb
might also contribute to this observation.
Together these data support a physiological role of Rev-erba
(and b) in intracellular as well as plasma lipid and lipoprotein
metabolism. These actions may inﬂuence the development of
pathologies such as type 2 diabetes and atherosclerosis, but
further studies are required to explore these potential activities
of Rev-erba.5.2. Adipocyte physiology
Rev-erba expression is induced during the adipogenic
process [14,37]. Furthermore, ectopic Rev-erba expression
in 3T3L1 pre-adipocytes promotes their diﬀerentiation into
mature adipocytes and enhances lipid storage [14]. This action
of Rev-erba is further enhanced by treatment with the PPARc
ligand rosiglitazone. As previously mentioned, PPARc ligands
induce Rev-erba expression and Rev-erbamay therefore trans-
duce some of PPARc’s physiological eﬀects. Indeed, Rev-erba
over-expression increases the expression of the PPARc target
genes aP2 and CCAAT/enhancer-binding protein (c/EBP)a,
but has no eﬀect on c/EBPb or SREBP-1 gene expression. To-gether these data indicate a role for Rev-erba in adipocyte
diﬀerentiation and physiology and identify Rev-erba as an adi-
pogenic gene downstream of PPARc. Another intriguing issue
is the well-documented association between alteration in feed-
ing periods seen in night shift or sleep restriction and weight
gain. The mechanisms involved therein have never been clearly
elucidated. In this regard it is very interesting to note that Rev-
erba can directly link the adipogenic process and the master
clock system. A large number of transcripts (leptin, adipokin-
es, and clock genes and nuclear receptors) cycle in adipose tis-
sue. Some functions of adipose tissue such as lipolysis and free
fatty acid release display circadian pulsatility. This aspect
deserves further investigations to better characterize the
adipose clock system and its function in the regulation of lipid
storage, adipokine synthesis, and secretion of peptides in-
volved in the (central) control of satiety and food intake.
5.3. Inﬂammation control
Rev-erba is expressed in diﬀerent cell types of the vascular
wall, namely ECs and VSMCs [15] as well as in cells from
the immune system such as macrophages ([15,55] and C. Fon-
taine and B. Staels, unpublished data). Rev-erba increases
tumor necrosis factor (TNF)a-induced nuclear factor jB
(NFjB) activation in VSMCs [15]. Furthermore, Rev-erba
over-expression in these cells resulted in an increased expres-
sion of the pro-inﬂammatory interleukine (IL)-6 and cycloxy-
genase (cox)-2 [15].
Rev-erba is highly expressed in chondrocytes, a cell type
found in cartilage releasing cytokines and matrix metallo-
proteinases (MMP) [56]. Rev-erba expression is increased in
cartilage under conditions of catabolic degradation such as
osteoarthritis. In these cells, Rev-erba induces the expression
of MMP-13 and aggrecanase and may amplify the degradation
process [57]. These data together with those reported in vascu-
lar cell types support the concept of a general implication of
Rev-erba in the inﬂammatory process.
5.4. Fibrinolysis cascade
The plasminogen activator inhibitor (PAI)-1 inhibits the
ﬁbrinolysis cascade and may promote the development of ath-
erothrombosis [58]. PAI-1 expression oscillates diurnally,
peaking late in the night. This PAI-1 peak correlates to mini-
mal ﬁbrinolytic activity and is associated with higher frequency
of acute thrombotic events [58]. RORa and Rev-erba compete
for the regulation of PAI-1 gene transcription: Rev-erba re-
presses RORa-mediated induction of PAI-1 transcription [59].6. Conclusion and perspectives
We have reviewed data identifying Rev-erba as a component
of the clock machinery and a crucial player in the maintenance
of circadian ﬂuctuations. A growing body of evidence also
indicates that Rev-erba regulates lipid metabolism and vascu-
lar inﬂammation and suggests it might play a modulatory role
in the development of cardio-vascular disease. Atherosclerosis
is a complex chronic inﬂammatory disease of the vascular wall
associated with metabolic abnormalities (i.e. dyslipidemia, glu-
cose disorders). The inﬂammatory reaction is initiated by the
accumulation of modiﬁed lipoproteins in the sub-endothelial
space of the vessels, resulting in the activation of ECs which
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Monocytes are recruited to the lesion site, diﬀerentiate into
macrophages which take up cholesterol and further ampliﬁy
the inﬂammatory reaction by secreting pro-inﬂammatory cyto-
kines and matrix metalloproteinases [60–62]. This ultimately
results in the rupture of unstable atherosclerotic plaques, and
acute occlusion by thrombosis leading to myocardial infarc-
tion and stroke [60]. Since Rev-erba regulates plasma lipid
and lipoprotein metabolism and the inﬂammatory reaction,
and may modulate the ﬁbrinolysis cascade, Rev-erba is likely
to modulate the onset of the atherogenic process and its con-
sequences in terms of acute cardiovascular events. It would
be therefore of interest in the future to determine whether
Rev-erba plays a role in atherosclerosis development.
Another exciting ﬁeld is the link between circadian rhythm
disorders and the development of obesity. We hypothesize that
Rev-erba may act as a molecular link between the adipogenic
process and the clock circuitry, although further studies are re-
quired to establish the role of Rev-erba in the modulation of
adipose tissue physiology by the clock system. This will help
get insights as to how feeding behaviour may inﬂuence the
clock system and reciprocally how the central and/or peripheral
pacemakers, via neuronal or hormonal signals, control appe-
tite, energy balance and body fat mass. Moreover, such studies
will help unravel whether alteration in the adipose clock system
can promote the development of obesity (and reciprocally).
Further studies are awaited to get further insights into Rev-
erba’s in vivo physiological role. It becomes clear that Rev-
erba is at the crossroad of several regulatory loops involving
other nuclear receptors that participate in the control of energy
homeostasis. We propose that Rev-erba is able to integrate
both circadian cues and signalling from other nuclear receptors
and bring about the ﬂexibility required for metabolic adjust-
ments.
Acknowledgement: This work has been supported by the European
Union Grant Diabesity (LSH-CT-2003-503041).References
[1] Grundy, S.M. (2006) Metabolic syndrome: connecting and
reconciling cardiovascular and diabetes worlds. J. Am. Coll.
Cardiol. 47, 1093–1100.
[2] Sharma, A.M., and Staels, B. (2007) Peroxisome proliferator-
activated receptor gamma and adipose tissue–understanding
obesity-related changes in regulation of lipid and glucose metab-
olism. J. Clin. Endocrinol. Metab, 92, 386–395.
[3] Boden, G., Chen, X. and Polansky, M. (1999) Disruption of
circadian insulin secretion is associated with reduced glucose
uptake in ﬁrst-degree relatives of patients with type 2 diabetes.
Diabetes 48, 2182–2188.
[4] Gangwisch, J.E., Malaspina, D., Boden-Albala, B. and Heyms-
ﬁeld, S.B. (2005) Inadequate sleep as a risk factor for obesity:
analyses of the NHANES I. Sleep 28, 1289–1296.
[5] Karlsson, B., Knutsson, A. and Lindahl, B. (2001) Is there an
association between shift work and having a metabolic syndrome?
Results from a population based study of 27,485 people. Occup.
Environ. Med. 58, 747–752.
[6] Chaput, J.P., Brunet, M. and Tremblay, A. (2006) Relationship
between short sleeping hours and childhood overweight/obesity:
results from the ‘Quebec en Forme’ Project. Int. J. Obes. (Lond)
30, 1080–1085.
[7] Ando, H., Yanagihara, H., Hayashi, Y., Obi, Y., Tsuruoka, S.,
Takamura, T., Kaneko, S. and Fujimura, A. (2005) Rhythmic
messenger ribonucleic acid expression of clock genes and adipo-cytokines in mouse visceral adipose tissue. Endocrinology 146,
5631–5636.
[8] Calvani, M., Scarfone, A., Granato, L., Mora, E.V., Nanni, G.,
Castagneto, M., Greco, A.V., Manco, M. and Mingrone, G.
(2004) Restoration of adiponectin pulsatility in severely obese
subjects after weight loss. Diabetes 53, 939–947.
[9] Yildiz, B.O., Suchard, M.A., Wong, M.L., McCann, S.M. and
Licinio, J. (2004) Alterations in the dynamics of circulating
ghrelin, adiponectin, and leptin in human obesity. Proc. Natl.
Acad. Sci. USA 101, 10434–10439.
[10] Turek, F.W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G.,
McDearmon, E., Laposky, A., Losee-Olson, S., Easton, A.,
Jensen, D.R., Eckel, R.H., Takahashi, J.S. and Bass, J. (2005)
Obesity and metabolic syndrome in circadian Clock mutant mice.
Science 308, 1043–1045.
[11] Rudic, R.D., McNamara, P., Curtis, A.M., Boston, R.C., Panda,
S., Hogenesch, J.B. and FitzGerald, G.A. (2004) BMAL1 and
CLOCK, two essential components of the circadian clock, are
involved in glucose homeostasis. PLoS Biol. 2, e377.
[12] Preitner, N., Damiola, F., Lopez-Molina, L., Zakany, J.,
Duboule, D., Albrecht, U. and Schibler, U. (2002) The orphan
nuclear receptor, R.E.V-ERBalpha controls circadian transcrip-
tion within the positive limb of the mammalian circadian
oscillator. Cell 110, 251–260.
[13] Raspe, E., Duez, H., Mansen, A., Fontaine, C., Fievet, C.,
Fruchart, J.C., Vennstrom, B. and Staels, B. (2002) Identiﬁcation
of Rev-erbalpha as a physiological repressor of apoC-III gene
transcription. J. Lipid Res. 43, 2172–2179.
[14] Fontaine, C., Dubois, G., Duguay, Y., Helledie, T., Vu-Dac, N.,
Gervois, P., Soncin, F., Mandrup, S., Fruchart, J.C., Fruchart-
Najib, J. and Staels, B. (2003) The orphan nuclear receptor Rev-
Erbalpha is a peroxisome proliferator-activated receptor (PPAR)
gamma target gene and promotes PPARgamma-induced adipo-
cyte diﬀerentiation. J. Biol. Chem. 278, 37672–37680.
[15] Migita, H., Morser, J. and Kawai, K. (2004) Rev-erbalpha
upregulates NF-kappaB-responsive genes in vascular smooth
muscle cells. FEBS Lett. 561, 69–74.
[16] Damiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-
Olela, F. and Schibler, U. (2000) Restricted feeding uncouples
circadian oscillators in peripheral tissues from the central pace-
maker in the suprachiasmatic nucleus. Genes Dev. 14, 2950–
2961.
[17] Kornmann, B., Schaad, O., Bujard, H., Takahashi, J.S. and
Schibler, U. (2007) System-driven and oscillator-dependent cir-
cadian transcription in mice with a conditionally active liver
clock. PLoS Biol. 5, e34.
[18] Panda, S., Antoch, M.P., Miller, B.H., Su, A.I., Schook, A.B.,
Straume, M., Schultz, P.G., Kay, S.A., Takahashi, J.S. and
Hogenesch, J.B. (2002) Coordinated transcription of key path-
ways in the mouse by the circadian clock. Cell 109, 307–320.
[19] Yang, X., Downes, M., Yu, R.T., Bookout, A.L., He, W.,
Straume, M., Mangelsdorf, D.J. and Evans, R.M. (2006) Nuclear
receptor expression links the circadian clock to metabolism. Cell
126, 801–810.
[20] Gachon, F., Nagoshi, E., Brown, S.A., Ripperger, J. and Schibler,
U. (2004) The mammalian circadian timing system: from gene
expression to physiology. Chromosoma 113, 103–112.
[21] Akashi, M. and Takumi, T. (2005) The orphan nuclear receptor
RORalpha regulates circadian transcription of the mammalian
core-clock Bmal1. Nat. Struct. Mol. Biol. 12, 441–448.
[22] Sato, T.K., Panda, S., Miraglia, L.J., Reyes, T.M., Rudic, R.D.,
McNamara, P., Naik, K.A., FitzGerald, G.A., Kay, S.A. and
Hogenesch, J.B. (2004) A functional genomics strategy reveals
Rora as a component of the mammalian circadian clock. Neuron
43, 527–537.
[23] Guillaumond, F., Dardente, H., Giguere, V. and Cermakian, N.
(2005) Diﬀerential control of Bmal1 circadian transcription by
REV-ERB and ROR nuclear receptors. J. Biol. Rhythms 20, 391–
403.
[24] Gallego, M. and Virshup, D.M. (2007) Post-translational mod-
iﬁcations regulate the ticking of the circadian clock. Nat. Rev.
Mol. Cell Biol. 8, 139–148.
[25] Yin, L., Wang, J., Klein, P.S. and Lazar, M.A. (2006) Nuclear
receptor Rev-erbalpha is a critical lithium-sensitive component of
the circadian clock. Science 311, 1002–1005.
H. Duez, B. Staels / FEBS Letters 582 (2008) 19–25 25[26] Renaud, J.P., Harris, J.M., Downes, M., Burke, L.J. and Muscat,
G.E. (2000) Structure–function analysis of the Rev-erbA and
RVR ligand-binding domains reveals a large hydrophobic surface
that mediates corepressor binding and a ligand cavity occupied by
side chains [In Process Citation]. Mol. Endocrinol. 14, 700–717.
[27] Lazar, M.A., Hodin, R.A., Darling, D.S. and Chin, W.W. (1989)
A novel member of the thyroid/steroid hormone receptor family is
encoded by the opposite strand of the rat c-erbA alpha
transcriptional unit. Mol. Cell Biol. 9, 1128–1136.
[28] Chomez, P., Neveu, I., Mansen, A., Kiesler, E., Larsson, L.,
Vennstrom, B. and Arenas, E. (2000) Increased cell death and
delayed development in the cerebellum of mice lacking the rev-
erbA(alpha) orphan receptor. Development 127, 1489–1498.
[29] Triqueneaux, G., Thenot, S., Kakizawa, T., Antoch, M.P., Saﬁ,
R., Takahashi, J.S., Delaunay, F. and Laudet, V. (2004) The
orphan receptor Rev-erbalpha gene is a target of the circadian
clock pacemaker. J. Mol. Endocrinol. 33, 585–608.
[30] Harding, H.P. and Lazar, M.A. (1995) The monomer-binding
orphan receptor Rev-Erb represses transcription as a dimer on a
novel direct repeat. Mol. Cell Biol. 15, 4791–4802.
[31] Harding, H.P. and Lazar, M.A. (1993) The orphan receptor Rev-
ErbA alpha activates transcription via a novel response element.
Mol. Cell Biol 13, 3113–3121.
[32] Forman, B.M., Chen, J., Blumberg, B., Kliewer, S.A., Henshaw,
R., Ong, E.S. and Evans, R.M. (1994) Cross-talk among ROR
alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol.
Endocrinol. 8, 1253–1261.
[33] Adelmant, G., Begue, A., Stehelin, D. and Laudet, V. (1996) A
functional Rev-erb alpha responsive element located in the human
Rev-erb alpha promoter mediates a repressing activity. Proc.
Natl. Acad. Sci. USA 93, 3553–3558.
[34] Raspe, E., Mautino, G., Duval, C., Fontaine, C., Duez, H.,
Barbier, O., Monte, D., Fruchart, J., Fruchart, J.C. and Staels, B.
(2002) Transcriptional regulation of human Rev-erbalpha gene
expression by the orphan nuclear receptor retinoic acid-related
orphan receptor alpha. J. Biol. Chem. 277, 49275–49281.
[35] Gervois, P., Chopin-Delannoy, S., Fadel, A., Dubois, G.,
Kosykh, V., Fruchart, J.C., Najib, J., Laudet, V. and Staels, B.
(1999) Fibrates increase human, R.E.V-ERBalpha expression in
liver via a novel peroxisome proliferator-activated receptor
response element. Mol. Endocrinol. 13, 400–409.
[36] Dumas, B., Harding, H.P., Choi, H.S., Lehmann, K.A., Chung,
M., Lazar, M.A. and Moore, D.D. (1994) A new orphan member
of the nuclear hormone receptor superfamily closely related to
Rev-Erb. Mol. Endocrinol. 8, 996–1005.
[37] Chawla, A. and Lazar, M.A. (1993) Induction of Rev-ErbA
alpha, an orphan receptor encoded on the opposite strand of the
alpha-thyroid hormone receptor gene, during adipocyte diﬀeren-
tiation. J. Biol. Chem. 268, 16265–16269.
[38] Pircher, P., Chomez, P., Yu, F., Vennstrom, B. and Larsson, L.
(2005) Aberrant expression of myosin isoforms in skeletal muscles
from mice lacking the rev-erbAalpha orphan receptor gene. Am.
J. Physiol Regul. Integr. Comp. Physiol 288, R482–R490.
[39] Balsalobre, A., Damiola, F. and Schibler, U. (1998) A serum
shock induces circadian gene expression in mammalian tissue
culture cells [see comments]. Cell 93, 929–937.
[40] Torra, I.P., Tsibulsky, V., Delaunay, F., Saladin, R., Laudet, V.,
Fruchart, J.C., Kosykh, V. and Staels, B. (2000) Circadian and
glucocorticoid regulation of Rev-erbalpha expression in liver.
Endocrinology 141, 3799–3806.
[41] Muhlbauer, E., Wolgast, S., Finckh, U., Peschke, D. and Peschke,
E. (2004) Indication of circadian oscillations in the rat pancreas.
FEBS Lett. 564, 91–96.
[42] Zvonic, S., Ptitsyn, A.A., Conrad, S.A., Scott, L.K., Floyd, Z.E.,
Kilroy, G., Wu, X., Goh, B.C., Mynatt, R.L. and Gimble, J.M.
(2006) Characterization of peripheral circadian clocks in adipose
tissues. Diabetes 55, 962–970.
[43] Le, M., inh, N., Damiola, F., Tronche, F., Schutz, G. and
Schibler, U. (2001) Glucocorticoid hormones inhibit food-induced
phase-shifting of peripheral circadian oscillators. EMBO J. 20,
7128–7136.
[44] Vu-Dac, N., Chopin-Delannoy, S., Gervois, P., Bonnelye, E.,
Martin, G., Fruchart, J.C., Laudet, V. and Staels, B. (1998) The
nuclear receptors peroxisome proliferator-activated receptoralpha and Rev-erbalpha mediate the species-speciﬁc regulation
of apolipoprotein A-I expression by ﬁbrates. J. Biol. Chem. 273,
25713–25720.
[45] Duez, H., Mansen, A., Fievet, C., Raspe, E., Fruchart, J.C.,
Vennstrom, B. and Staels, B. (2000) Rev-erba : an orphan nuclear
receptor regulating lipoprotein metabolism. Atherosclerosis 149,
229–238.
[46] Vu-Dac, N., Gervois, P., Grotzinger, T., De Vos, P., Schoonjans,
K., Fruchart, J.C., Auwerx, J., Mariani, J., Tedgui, A. and Staels,
B. (1997) Transcriptional regulation of apolipoprotein A-I gene
expression by the nuclear receptor RORalpha. J. Biol. Chem. 272,
22401–22404.
[47] Raspe, E., Duez, H., Gervois, P., Fievet, C., Fruchart, J.C.,
Besnard, S., Mariani, J., Tedgui, A. and Staels, B. (2000)
Transcriptional regulation of apolipoprotein C-III gene expres-
sion by the orphan nuclear receptor RORalpha. J. Biol. Chem.
[48] Mamontova, A., Seguret-Mace, S., Esposito, B., Chaniale, C.,
Bouly, M., Delhaye-Bouchaud, N., Luc, G., Staels, B., Duverger,
N., Mariani, J. and Tedgui, A. (1998) Severe atherosclerosis and
hypoalphalipoproteinemia in the staggerer mouse, a mutant of the
nuclear receptor RORalpha. Circulation 98, 2738–2743.
[49] Anzulovich, A., Mir, A., Brewer, M., Ferreyra, G., Vinson, C.
and Baler, R. (2006) Elovl3: a model gene to dissect homeostatic
links between the circadian clock and nutritional status. J. Lipid
Res. 47, 2690–2700.
[50] Kassam, A., Capone, J.P. and Rachubinski, R.A. (1999) Orphan
nuclear hormone receptor RevErbalpha modulates expression
from the promoter of the hydratase-dehydrogenase gene by
inhibiting peroxisome proliferator-activated receptor alpha-
dependent transactivation. J. Biol. Chem. 274, 22895–22900.
[51] Hsu, M.H., Palmer, C.N., Song, W., Griﬃn, K.J. and Johnson,
E.F. (1998) A carboxyl-terminal extension of the zinc ﬁnger
domain contributes to the speciﬁcity and polarity of peroxisome
proliferator-activated receptor DNA binding. J. Biol. Chem. 273,
27988–27997.
[52] Canaple, L., Rambaud, J., Dkhissi-Benyahya, O., Rayet, B., Tan,
N.S., Michalik, L., Delaunay, F., Wahli, W. and Laudet, V.
(2006) Reciprocal regulation of brain and muscle Arnt-like
protein 1 and peroxisome proliferator-activated receptor alpha
deﬁnes a novel positive feedback loop in the rodent liver circadian
clock. Mol. Endocrinol. 20, 1715–1727.
[53] Inoue, I., Shinoda, Y., Ikeda, M., Hayashi, K., Kanazawa, K.,
Nomura, M., Matsunaga, T., Xu, H., Kawai, S., Awata, T.,
Komoda, T. and Katayama, S. (2005) CLOCK/BMAL1 is
involved in lipid metabolism via transactivation of the peroxisome
proliferator-activated receptor (PPAR) response element. J.
Atheroscler. Thromb. 12, 169–174.
[54] Ramakrishnan, S.N., Lau, P., Burke, L.J. and Muscat, G.E.
(2005) Rev-erbbeta regulates the expression of genes involved in
lipid absorption in skeletal muscle cells: evidence for cross-talk
between orphan nuclear receptors and myokines. J. Biol. Chem.
280, 8651–8659.
[55] Barish, G.D., Downes, M., Alaynick, W.A., Yu, R.T., Ocampo,
C.B., Bookout, A.L., Mangelsdorf, D.J. and Evans, R.M. (2005)
A nuclear receptor atlas: macrophage activation. Mol. Endocri-
nol. 19, 2466–2477.
[56] Fernandes, J.C., Martel-Pelletier, J., and Pelletier, J.P., (2002) The
role of cytokines in osteoarthritis pathophysiology. Biorheology
39, 237–246.
[57] Chaturvedi, P., Pratta, M., Steplewski, K., Connor, J. and
Kumar, S. (2006) Functional characterization of an orphan
nuclear receptor, Rev-ErbAalpha, in chondrocytes and its
potential role in osteoarthritis. Arthritis Rheum. 54, 3513–3522.
[58] Vaughan, D.E. (2005) PAI-1 and atherothrombosis. J. Thromb.
Haemost. 3, 1879–1883.
[59] Wang, J., Yin, L. and Lazar, M.A. (2006) The orphan nuclear
receptor Rev-erb alpha regulates circadian expression of plasmin-
ogen activator inhibitor type 1. J. Biol. Chem. 281, 33842–33848.
[60] Lusis, A.J. (2000) Atherosclerosis. Nature 407, 233–241.
[61] Boisvert, W.A. (2004) Modulation of atherogenesis by chemo-
kines. Trends Cardiovasc. Med. 14, 161–165.
[62] Koenig, W. and Khuseyinova, N. (2007) Biomarkers of athero-
sclerotic plaque instability and rupture. Arterioscler. Thrombosis
Vasc. Biol. 27, 15–26.
